OCX Insight Molecular Diagnostics Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $5.69M and sold $0 on the open market.
Recent OCX insider trades
- Apr 27, 2026: Broadwood Partners, L.P. bought 570,184 shares ($2.03M)
- Apr 20, 2026: Broadwood Partners, L.P. bought 182,861 shares ($653K)
- Feb 10, 2026: Broadwood Partners, L.P. bought 521,739 shares ($3.00M)
- Feb 7, 2025: Smith Patrick W bought 1,077,600 shares ($2.21M)
5%+ owners
- Neal C. Bradsher: 39.7% (Schedule 13D/A, filed Apr 27, 2026)
- AWM Investment Company, Inc.: 10.0% (Schedule 13G/A, filed May 9, 2025)
- BIO-RAD LABORATORIES, INC: 9.7% (Schedule 13G/A, filed Mar 4, 2025)